![Christian Weyer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christian Weyer
President bij Escient Pharmaceuticals, Inc.
Actieve functies van Christian Weyer
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Escient Pharmaceuticals, Inc.
![]() Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | Hoofd Techniek/Wetenschap/O&O | 18-05-2021 | - |
President | 18-05-2021 | - |
Loopbaan van Christian Weyer
Eerdere bekende functies van Christian Weyer
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Profil Institute for Clinical Research, Inc.
![]() Profil Institute for Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Profil Institute for Clinical Research, Inc. operates as a full-service clinical research organization (CRO), that focuses on diabetes, obesity and NAFLD/NASH. It offers clinical development, regulatory affair, clinical research, scientific, data management and statistical, monitoring, quality and compliance, and recruitment services. The company was founded in 2004 and is headquartered in Chula Vista, CA. | President | 01-12-2015 | 01-11-2017 |
ProSciento, Inc.
![]() ProSciento, Inc. Miscellaneous Commercial ServicesCommercial Services ProSciento, Inc. is a full-service clinical research organization that works with biopharma companies worldwide to support their outsourced clinical research needs. The company is based in Chula Vista, CA, and has subsidiaries in the United States. The company specializes in providing comprehensive and customized services for multinational, early development clinical trial programs for metabolic continuum diseases, including diabetes, obesity, and steatotic liver disease. ProSciento has conducted over 300 clinical projects and supported the development of many approved metabolic drugs and devices on the market. ProSciento was founded in 2003, and Marcus Hompesch has been the CEO of the company since its inception. | President | 01-12-2015 | 01-11-2017 |
FATE THERAPEUTICS, INC. | Directeur/Bestuurslid | 15-10-2012 | 01-11-2015 |
Algemeen Directeur | 15-10-2012 | 01-11-2015 | |
President | 15-10-2012 | 01-11-2015 | |
Amylin Pharmaceuticals, Inc.
![]() Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Hoofd Techniek/Wetenschap/O&O | 03-06-2010 | - |
INTERCEPT PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 27-11-2017 | - |
EKF-diagnostic GmbH
![]() EKF-diagnostic GmbH Medical SpecialtiesHealth Technology EKF-diagnostic GmbH engages in the development, manufacture, and distribution of medical equipment. It produces point of care analyzers for the measurement of glucose, lactate, hemoglobin, hematocrit, and glycated hemoglobin. Its products include Quo-Test, Quo-Lab, Biosen, CardioChek Plus, Lactate Scout+, Hemo Control, Crematocrit Plus, Hemo Vet, and DiaSpectTM. The company was founded by Berthold Walter in 1990 and is headquartered in Barleben, Germany. | Comptroller/Controller/Auditor | - | - |
Verkoop & Marketing | - | - |
Opleiding van Christian Weyer
University of California San Diego | Graduate Degree |
Heinrich-Heine-Universität Düsseldorf | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 8 |
Duitsland | 3 |
Operationeel
President | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Comptroller/Controller/Auditor | 1 |
Sectoraal
Health Technology | 6 |
Consumer Services | 3 |
Commercial Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
FATE THERAPEUTICS, INC. | Health Technology |
INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
EKF-diagnostic GmbH
![]() EKF-diagnostic GmbH Medical SpecialtiesHealth Technology EKF-diagnostic GmbH engages in the development, manufacture, and distribution of medical equipment. It produces point of care analyzers for the measurement of glucose, lactate, hemoglobin, hematocrit, and glycated hemoglobin. Its products include Quo-Test, Quo-Lab, Biosen, CardioChek Plus, Lactate Scout+, Hemo Control, Crematocrit Plus, Hemo Vet, and DiaSpectTM. The company was founded by Berthold Walter in 1990 and is headquartered in Barleben, Germany. | Health Technology |
Amylin Pharmaceuticals, Inc.
![]() Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
Profil Institute for Clinical Research, Inc.
![]() Profil Institute for Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Profil Institute for Clinical Research, Inc. operates as a full-service clinical research organization (CRO), that focuses on diabetes, obesity and NAFLD/NASH. It offers clinical development, regulatory affair, clinical research, scientific, data management and statistical, monitoring, quality and compliance, and recruitment services. The company was founded in 2004 and is headquartered in Chula Vista, CA. | Commercial Services |
ProSciento, Inc.
![]() ProSciento, Inc. Miscellaneous Commercial ServicesCommercial Services ProSciento, Inc. is a full-service clinical research organization that works with biopharma companies worldwide to support their outsourced clinical research needs. The company is based in Chula Vista, CA, and has subsidiaries in the United States. The company specializes in providing comprehensive and customized services for multinational, early development clinical trial programs for metabolic continuum diseases, including diabetes, obesity, and steatotic liver disease. ProSciento has conducted over 300 clinical projects and supported the development of many approved metabolic drugs and devices on the market. ProSciento was founded in 2003, and Marcus Hompesch has been the CEO of the company since its inception. | Commercial Services |
Escient Pharmaceuticals, Inc.
![]() Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | Health Technology |
- Beurs
- Insiders
- Christian Weyer
- Ervaring